Liposomal encapsulation of amoxicillin via microfluidics with subsequent investigation of the significance of PEGylated therapeutics.

MLA

Weaver, Edward, et al. “Liposomal Encapsulation of Amoxicillin via Microfluidics with Subsequent Investigation of the Significance of PEGylated Therapeutics.” International Journal of Pharmaceutics, vol. 650, Jan. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2023.123710.

APA

Weaver, E., Macartney, R. A., Irwin, R., Uddin, S., Hooker, A., Burke, G. A., Wylie, M. P., & Lamprou, D. A. (2024). Liposomal encapsulation of amoxicillin via microfluidics with subsequent investigation of the significance of PEGylated therapeutics. International Journal of Pharmaceutics, 650, N.PAG. https://doi.org/10.1016/j.ijpharm.2023.123710

Chicago

Weaver, Edward, Robyn A. Macartney, Robyn Irwin, Shahid Uddin, Andrew Hooker, George A. Burke, Matthew P. Wylie, and Dimitrios A. Lamprou. 2024. “Liposomal Encapsulation of Amoxicillin via Microfluidics with Subsequent Investigation of the Significance of PEGylated Therapeutics.” International Journal of Pharmaceutics 650 (January): N.PAG. doi:10.1016/j.ijpharm.2023.123710.